Millennium II Materials Technology Fund

Enzymotec Ltd. is a biotechnology company based in Migdal Haemeq, Israel, specializing in the development, manufacturing, and marketing of bio-functional lipid ingredients and medical foods. The company caters to diverse health needs across the human life cycle, producing nutritional products for infants, adults, and seniors. Its Nutrition segment offers lipid-based ingredients such as phospholipids, which are essential for cell membrane structure, and includes products like Infant, a lipid ingredient for infant formula, and various phosphatidylserine supplements aimed at enhancing cognitive performance. The VAYA Pharma segment focuses on lipid-based medical foods designed for cardiovascular and neurological health, with products like Vayarin for managing lipid imbalances related to attention deficit-hyperactivity disorder and Vayacog for early memory impairment. Enzymotec's innovative approach addresses health issues through advanced lipid-based solutions, supporting the nutritional supplement, healthcare, and medical food industries. The company was founded in 1998 and operates as a subsidiary of Frutarom Ltd.

Mempile developed removable storage technology for the healthcare, public, entertainment, security, financial & business sectors. It focused on developing optical storage that is designed to hold up to one Terabyte of information on a single removable disc. The company offered its products for use in applications, such as home archiving, entertainment, public sector, business compliance, healthcare & video monitoring. Mempile had a development center in the United States & a business development unit in Japan. Mempile was founded in 2000 and was based in Yehuda, Israel. It closed down as of January 2009.

Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

Cymbet develops market eco-friendly, biocompatible rechargeable solid state batteries that provide electronic systems designers with new embedded power capabilities. Cymbet’s EnerChip batteries allow new concepts in energy storage application for ICs and new products for medical, sensor, RFID, industrial control, communications, and portable electronic devices. Their new single chip Power Management Real-Time Clock (PMRTC) device is a world class device and among the lowest power RTCs in the industry.

Mempile developed removable storage technology for the healthcare, public, entertainment, security, financial & business sectors. It focused on developing optical storage that is designed to hold up to one Terabyte of information on a single removable disc. The company offered its products for use in applications, such as home archiving, entertainment, public sector, business compliance, healthcare & video monitoring. Mempile had a development center in the United States & a business development unit in Japan. Mempile was founded in 2000 and was based in Yehuda, Israel. It closed down as of January 2009.

Mempile developed removable storage technology for the healthcare, public, entertainment, security, financial & business sectors. It focused on developing optical storage that is designed to hold up to one Terabyte of information on a single removable disc. The company offered its products for use in applications, such as home archiving, entertainment, public sector, business compliance, healthcare & video monitoring. Mempile had a development center in the United States & a business development unit in Japan. Mempile was founded in 2000 and was based in Yehuda, Israel. It closed down as of January 2009.